Henry Schein Q2 Earnings Miss Estimates, Revenue Grows 3.3%
ByAinvest
Tuesday, Aug 5, 2025 12:57 pm ET1min read
HSIC--
Total net sales for the quarter reached $3.2 billion, a 3.3% increase from the prior-year period. This growth was driven by a 1.9% internal sales growth, a 0.8% sales growth from acquisitions, and a 0.6% increase due to foreign currency exchange [1].
However, profitability and margins fell due to softening U.S. dental sales. Global Dental Distribution merchandise sales increased by 0.3%, but decreased 0.4% in constant currencies compared to the same period last year. U.S. volume increased at lower average selling prices, partly due to lower glove pricing and time-limited targeted sales initiatives [1].
The company's Specialty Products and Technology Groups continued to deliver strong results, driven primarily by sales from innovative products and solutions, and cost efficiencies [1]. Global Technology sales increased by 7.4%, with practice management systems like Dentrix Ascend and Dentally cloud-based solutions contributing significantly to this growth [1].
Henry Schein's focus on expanding specialty products, technology solutions, and value-added services, as well as strategic acquisitions and partnerships, remains key to its success. The company is maintaining its guidance for 2025, expecting non-GAAP diluted EPS to be $4.80 to $4.94, reflecting growth of 1% to 4% over 2024 [1].
The company also reported that it repurchased approximately 3.7 million shares of common stock at an average price of $70.88 per share for a total of $259 million during the second quarter of 2025 [1].
References:
[1] https://investor.henryschein.com/news-releases/news-release-details/henry-schein-reports-second-quarter-2025-financial-results
Henry Schein's Q2 EPS dropped 11% to $1.10, missing analyst expectations by 7.6%. Revenue reached $3.24 billion, increasing 3.3% compared to the prior-year period. Profitability and margins fell due to softening U.S. dental sales and declining GAAP and non-GAAP net income and Adjusted EBITDA compared to the prior-year period. The company's focus on expanding specialty products, technology solutions, and value-added services, as well as strategic acquisitions and partnerships, remains key to its success.
Henry Schein, Inc. (Nasdaq: HSIC) reported its second-quarter 2025 financial results, showing mixed performance with a notable drop in earnings per share (EPS) and a slight increase in revenue. The company's quarterly GAAP diluted EPS fell to $0.70, a 11% decline compared to the same period in 2024, which was $0.80 per share [1]. Non-GAAP diluted EPS dropped to $1.10, down 11% from $1.23 in the second quarter of 2024 [1].Total net sales for the quarter reached $3.2 billion, a 3.3% increase from the prior-year period. This growth was driven by a 1.9% internal sales growth, a 0.8% sales growth from acquisitions, and a 0.6% increase due to foreign currency exchange [1].
However, profitability and margins fell due to softening U.S. dental sales. Global Dental Distribution merchandise sales increased by 0.3%, but decreased 0.4% in constant currencies compared to the same period last year. U.S. volume increased at lower average selling prices, partly due to lower glove pricing and time-limited targeted sales initiatives [1].
The company's Specialty Products and Technology Groups continued to deliver strong results, driven primarily by sales from innovative products and solutions, and cost efficiencies [1]. Global Technology sales increased by 7.4%, with practice management systems like Dentrix Ascend and Dentally cloud-based solutions contributing significantly to this growth [1].
Henry Schein's focus on expanding specialty products, technology solutions, and value-added services, as well as strategic acquisitions and partnerships, remains key to its success. The company is maintaining its guidance for 2025, expecting non-GAAP diluted EPS to be $4.80 to $4.94, reflecting growth of 1% to 4% over 2024 [1].
The company also reported that it repurchased approximately 3.7 million shares of common stock at an average price of $70.88 per share for a total of $259 million during the second quarter of 2025 [1].
References:
[1] https://investor.henryschein.com/news-releases/news-release-details/henry-schein-reports-second-quarter-2025-financial-results

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet